Trial | NCT02199678  Report issue

Title

A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction
A Randomized,Double Blind, Parallel Group, Placebo Controlled Dose Ranging Study to Assess the Analgesic Efficacy, Tolerability, Safety and Pharmacokinetic/Pharmacodynamic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Indication/Condition

    Pain

  • Intervention/Treatment

    ketamine ...

  • Study Participants

    120
This is a Phase 2, randomized, multicenter, parallel group, double-blind, dose-ranging, placebo-controlled evaluation of the analgesic efficacy, safety and pharmacokinetics of ketamine sublingual wafer in adult subjects who experience post operative pain after undergoing third molar extraction.
Study Started
Jul 31
2014
Primary Completion
Nov 30
2014
Study Completion
Nov 30
2014
Last Update
Nov 21
2014
Estimate

Drug Placebo

placebo

Drug ketamine 25 mg

ketamine

Drug ketamine 35 mg

ketamine

Drug ketamine 50 mg

ketamine

Placebo Placebo Comparator

Placebo

ketamine 25 mg Active Comparator

ketamine

ketamine 35 mg Active Comparator

ketamine

ketamine 50 mg Active Comparator

ketamine

Criteria 

18- 38 years of age Scheduled to undergo two ipsilateral third molar extractions
No Results Posted